Literature DB >> 22038112

Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients.

G Bayramoglu1, S Kaya, Y Besli, E Cakır, G Can, O Akıneden, F Aydin, I Koksal.   

Abstract

OBJECTIVE: This study was intended to investigate the clinical significance and molecular epidemiology of Acinetobacter baumannii complex (ABC) isolated from cerebrospinal fluid (CSF) in neurosurgical intensive care unit (NSICU) patients, particularly comparing isolates from healthcare workers' (HCW) hands.
METHODS: We retrospectively reviewed the medical records of 30 patients with CSF cultures positive for ABC seen at our NSICU from the date it first opened, January 2007, to September 2010. Pulsed-field gel electrophoresis (PFGE) typing was performed on 68 strains isolated from 32 patients' CSF and 36 HCWs' hands.
RESULTS: ABC isolates were considered to be clinically significant in 21 (70.0%) patients but insignificant in the other nine (30.0%) patients. The prolonged (>7 days) use of cephalosporins was more common in patients with clinically significant ABC isolates (p = 0.049). Multiple drug resistance (MDR) was observed in 12 (57.1%) clinically significant isolates. Empirical antimicrobial therapies were not appropriate for nine of these 21 patients (42.8%). Mortality was significantly higher in the clinically significant group than in the clinically insignificant group (18/21 vs. 3/9; p = 0.008). Fifty-three isolates (77.9%) were grouped into 15 clusters, three of which contained possibly related isolates from patients' CSF and staff members' hands.
CONCLUSIONS: The fact that ABC isolates grown from CSF cultures do not always exhibit infection and have high multiple antibiotic resistance, including to carbapenems, should be borne in mind when planning treatment for these patients. In addition, HCWs' hands may play a significant role in transmission to patients, and compliance with infection control procedures, especially hand washing, must be enhanced in order to avoid ABC infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038112     DOI: 10.1007/s15010-011-0215-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

Review 1.  Infections in patients with traumatic brain injury who undergo neurosurgery.

Authors:  Irene S Kourbeti; John A Papadakis; Christodoulos Neophytou; Maria Filippou; Antonis Ioannou; Dimitris A Karabetsos; George Bertsias; Maria Anastasaki; Antonis F Vakis
Journal:  Br J Neurosurg       Date:  2010-07-22       Impact factor: 1.596

2.  CSF markers for diagnosis of bacterial meningitis in neurosurgical postoperative patients.

Authors:  Wagner Malagó Tavares; Andre Guelman Machado; Hamilton Matushita; Jose Pindaro P Plese
Journal:  Arq Neuropsiquiatr       Date:  2006-09       Impact factor: 1.420

3.  Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance.

Authors:  Gokhan Metan; Emine Alp; Bilgehan Aygen; Bulent Sumerkan
Journal:  J Antimicrob Chemother       Date:  2007-05-31       Impact factor: 5.790

4.  Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii.

Authors:  Harald Seifert; Lucilla Dolzani; Raffaela Bressan; Tanny van der Reijden; Beppie van Strijen; Danuta Stefanik; Herre Heersma; Lenie Dijkshoorn
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Analysis of three variables in sampling solutions used to assay bacteria of hands: type of solution, use of antiseptic neutralizers, and solution temperature.

Authors:  E L Larson; M S Strom; C A Evans
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

6.  Gram-negative bacillary meningitis after cranial surgery or trauma in adults.

Authors:  Simon Briggs; Rod Ellis-Pegler; Nigel Raymond; Mark Thomas; Lucille Wilkinson
Journal:  Scand J Infect Dis       Date:  2004

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.

Authors:  M H Nguyen; S P Harris; R R Muder; A W Pasculle
Journal:  Neurosurgery       Date:  1994-11       Impact factor: 4.654

9.  Clinical features, laboratory data, management and the risk factors that affect the mortality in patients with postoperative meningitis.

Authors:  Ilknur Erdem; Tayfun Hakan; Nurgul Ceran; Fatma Metin; Seniha Senbayrak Akcay; Metin Kucukercan; M Zafer Berkman; Pasa Goktas
Journal:  Neurol India       Date:  2008 Oct-Dec       Impact factor: 2.117

10.  Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006.

Authors:  M Wadl; K Heckenbach; I Noll; S Ziesing; W Pfister; J Beer; S Schubert; T Eckmanns
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

View more
  3 in total

Review 1.  Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature.

Authors:  R Giua; C Pedone; L Cortese; R Antonelli Incalzi
Journal:  Infection       Date:  2013-07-25       Impact factor: 3.553

2.  Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.

Authors:  T Coelho-Souza; J N Reis; N Martins; I S Martins; A O Menezes; M G Reis; N O Silva; R C S Dias; L W Riley; B M Moreira
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

3.  Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii.

Authors:  Dom Mahoney; David Porter; Mahableshwar Albur
Journal:  IDCases       Date:  2017-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.